ASS1 and prostate carcinoma: In addition, in these ASS1-low CWR22Rv1 prostate cancer cells, ADI induced a novel type of cell killing, which is caspase-independent, but autophagy-, mitochondria- and ROS-dependent 2, 21, 23.